The Cure Sickle Cell Initiative Economic Analysis: An Evaluation of the Costs of Sickle Cell Disease and Potential Health Plan Budget Impacts of Gene Therapy as a New Treatment Option
$390,634OT3FY2019HLNIH
Fred Hutchinson Cancer Center, Seattle WA
Fred Hutchinson Cancer Center, Seattle WA